Candel Therapeutics, Inc. (CADL) financial statements and ratios from SEC XBRL: revenue $2.08M (TTM), net margin -1823.1%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $2.08M |
| Net Margin | -1823.1% |
| Price / Book | 7.49 |
| Price / Sales | 639.30 |
| FCF Yield | -5.9% |
| Sector P/E (Healthcare) | 21.6 |
CADL overview · CADL earnings · CADL KPIs · CADL investor relations · CADL ownership · CADL peers · CADL filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.